Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Orthobiologics Devices And Equipment Market Size And Revenue Outlook Through 2030
The orthobiologics devices and equipment market size has experienced substantial growth in recent years. This market is projected to expand from $5.99 billion in 2025 to $6.36 billion in 2026, at a compound annual growth rate (CAGR) of 6.2%. The historical period’s growth can be attributed to the rise in musculoskeletal disorders, the prevalence of sports injuries, the increase in orthopedic surgeries, the adoption of PRP therapies, and the clinical success of bone grafts.
The orthobiologics devices and equipment market is projected to experience robust expansion over the coming years. Its valuation is anticipated to reach $8.64 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 8.0%. This projected increase during the forecast period is primarily driven by factors such as the expanding aging population, advancements in regenerative medicine, a rising demand for minimally invasive treatments, broader reimbursement policies, and innovations in biomaterial technology. Key developments expected within this period include a greater embrace of regenerative therapies, an increase in treatments for sports injuries, the growing application of stem cell-based products, a preference for non-surgical orthopedic solutions, and the proliferation of orthopedic clinics.
Get A Free Sample Report With In-Depth Market Insights:
Orthobiologics Devices And Equipment Market Expansion Drivers: What’s Shaping Future Growth?
The rising occurrence of orthopedic conditions is anticipated to fuel the expansion of the orthobiologics devices and equipment market in the future. Orthopedic disorders are defined as ailments impacting the musculoskeletal system, including bones, joints, muscles, ligaments, tendons, and nerves. The increasing global elderly population, which is more prone to musculoskeletal conditions such as osteoarthritis, osteoporosis, and fractures, is escalating the demand for orthopedic treatments. Orthobiologics devices and equipment help address orthopedic disorders by supporting natural tissue regeneration and more effectively restoring bone and joint function. They enhance treatment outcomes by improving healing efficiency and shortening patient recovery times. For instance, in August 2023, a survey study from the Institute for Health Metrics and Evaluation, a US-based public health research institute, indicated that 15% of individuals aged 30 and older had osteoarthritis in 2023, and the number of affected individuals is projected to reach around 1 billion by 2050. Thus, the increasing prevalence of orthopedic disorders is driving the growth of the orthobiologics devices and equipment market.
Orthobiologics Devices And Equipment Market Segment Analysis: What Are The Core Market Categories?
The orthobiologics devices and equipment market covered in this report is segmented –
1) By Product Type: Demineralized Bone Matrix, Synthetic Bone Substitutes, Stem Cell Therapy, Plasma-Rich Protein, Viscosupplementation, Bone Morphogenetic Protein, Synthetic Orthobiologics
2) By Application: Osteoarthritis And Degenerative Arthritis, Soft-Tissue Injuries, Fracture Recovery, Maxillofacial And Dental Applications, Spinal Fusion, Trauma Repair, Reconstructive Surgery
3) By End Use: Hospitals, Orthopedic Clinics, Other End Users
Subsegments:
1) By Demineralized Bone Matrix: Injectable Demineralized Bone Matrix, Paste And Putty Forms, Demineralized Bone Matrix Scaffolds
2) By Synthetic Bone Substitutes: Calcium Phosphate Ceramics, Bioactive Glasses, Polymers And Composites
3) By Stem Cell Therapy: Adipose-Derived Stem Cell Products, Bone Marrow-Derived Stem Cell Products, Umbilical Cord Blood-Derived Stem Cell Products
4) By Plasma-Rich Protein: Platelet-Rich Plasma (PRP) Products, Platelet-Rich Fibrin (PRF) Products
5) By Viscosupplementation: Hyaluronic Acid Injections, Combination Viscosupplementation Products
6) By Bone Morphogenetic Protein (BMP): Recombinant Bone Morphogenetic Proteins, BMP Delivery Systems
7) By Synthetic Orthobiologics: Growth Factor-Enhanced Products, Biodegradable Scaffolds With Bioactive Agents, Other Synthetic Formulations
Orthobiologics Devices And Equipment Market Strategic Trends: What Defines The Next Growth Phase?
Leading companies within the orthobiologics devices and equipment market are concentrating on developing advanced regenerative solutions, such as synthetic bone fusion gels, to enhance surgical outcomes, promote healing, and minimize complications. Synthetic bone fusion gels are sophisticated biomaterial formulations that function as a scaffold and delivery system for growth factors, encouraging bone growth in spinal fusion and orthopedic procedures. For instance, in January 2024, Renovos Biologics Ltd., a UK-based biomaterial company and investee of Biocomposites, secured Food and Drug Administration (FDA) Breakthrough Device Designation for its synthetic nanoclay bone fusion gel, Renovite BMP-2. This novel, injectable, and moldable gel is engineered to contain and retain bone morphogenetic protein-2 (BMP-2) precisely at the surgical site. The technology aims to foster effective bone healing while reducing the risk of ectopic bone formation and other soft-tissue complications often linked with older carrier systems, thereby facilitating a more controlled and efficient fusion process.
Orthobiologics Devices And Equipment Market Competitive Analysis Of Leading Industry Participants
Major companies operating in the orthobiologics devices and equipment market are BONESUPPORT AB, Medtronic plc, Kuros Biosciences Ltd., Stryker Corporation, Baxter International Inc., DePuy Synthes, Braun Melsungen AG, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Arthrex Inc., Enovis Corp., Integra Lifesciences Holding Corporation, NuVasive Inc., Globus Medical Inc., Bioventus LLC, Orthofix Medical Inc., SeaSpine Holdings Corporation, Xtant Medical Holdings Inc., Acumed LLC, Bone Biologics Corp.
View The Full Orthobiologics Devices And Equipment Market Report:
Orthobiologics Devices And Equipment Market Geographic Spread And Regional Opportunities
North America was the largest region in the global Ortho biologics devices and equipment market in 2025. Western Europe was the second-largest region in the orthobiologics devices and equipment market report. The regions covered in the orthobiologics devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
